StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BioLineRx's market cap was $6.12M on Nov 11, 2026, against $6.93M a year earlier. Over the last 5 years it ranged from $5.38M to $93.91M, with a median of $30.68M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.12M+10.7%
2025Dec 31, 2025$5.53M-59.8%
2024Dec 31, 2024$13.74M-83.0%
2023Dec 29, 2023$81.01M+210.7%
2022Dec 30, 2022$26.08M-24.2%
2021Dec 31, 2021$34.39M+39.8%
2020Dec 31, 2020$24.60M+51.0%
2019Dec 31, 2019$16.29M-58.6%
2018Dec 31, 2018$39.34M-35.7%
2017Dec 29, 2017$61.19M+29.4%
2016Dec 30, 2016$47.29M–

More BioLineRx figures

See a number that looks wrong?